Celularity Inc. (CELU)

Celularity Statistics

Total Valuation

Celularity has a market cap or net worth of $25.25 million. The enterprise value is $93.79 million.

Market Cap	25.25M
Enterprise Value	93.79M

Important Dates

The last earnings date was Thursday, April 30, 2026, after market close.

Earnings Date	Apr 30, 2026
Ex-Dividend Date	n/a

Share Statistics

Celularity has 28.95 million shares outstanding. The number of shares has increased by 16.94% in one year.

Current Share Class	28.95M
Shares Outstanding	28.95M
Shares Change (YoY)	+16.94%
Shares Change (QoQ)	+8.00%
Owned by Insiders (%)	12.24%
Owned by Institutions (%)	13.13%
Float	18.87M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	0.95
Forward PS	n/a
PB Ratio	n/a
P/TBV Ratio	n/a
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Enterprise Valuation

EV / Earnings	n/a
EV / Sales	3.53
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	n/a

Financial Position

The company has a current ratio of 0.15

Current Ratio	0.15
Quick Ratio	0.13
Debt / Equity	n/a
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	-8.79

Financial Efficiency

Return on Equity (ROE)	n/a
Return on Assets (ROA)	-30.93%
Return on Invested Capital (ROIC)	-153.63%
Return on Capital Employed (ROCE)	-221.05%
Weighted Average Cost of Capital (WACC)	7.07%
Revenue Per Employee	$230,870
Profits Per Employee	-$798,261
Employee Count	115
Asset Turnover	0.22
Inventory Turnover	6.71

Taxes

In the past 12 months, Celularity has paid $3,000 in taxes.

Income Tax	3,000
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -57.66% in the last 52 weeks. The beta is 0.48, so Celularity's price volatility has been lower than the market average.

Beta (5Y)	0.48
52-Week Price Change	-57.66%
50-Day Moving Average	1.06
200-Day Moving Average	1.59
Relative Strength Index (RSI)	40.87
Average Volume (20 Days)	155,807

Short Selling Information

The latest short interest is 373,196, so 1.29% of the outstanding shares have been sold short.

Short Interest	373,196
Short Previous Month	275,407
Short % of Shares Out	1.29%
Short % of Float	1.98%
Short Ratio (days to cover)	2.36

Income Statement

In the last 12 months, Celularity had revenue of $26.55 million and -$91.80 million in losses. Loss per share was -$3.59.

Revenue	26.55M
Gross Profit	6.48M
Operating Income	-59.40M
Pretax Income	-91.71M
Net Income	-91.80M
EBITDA	-54.01M
EBIT	-59.40M
Loss Per Share	-$3.59

Balance Sheet

The company has $6.18 million in cash and $74.71 million in debt, with a net cash position of -$68.54 million or -$2.37 per share.

Cash & Cash Equivalents	6.18M
Total Debt	74.71M
Net Cash	-68.54M
Net Cash Per Share	-$2.37
Equity (Book Value)	-37.76M
Book Value Per Share	-1.32
Working Capital	-68.14M

Cash Flow

Operating Cash Flow	-13.25M
Capital Expenditures	n/a
Depreciation & Amortization	5.38M
Net Borrowing	10.79M
Free Cash Flow	-13.25M
FCF Per Share	-$0.46

Margins

Gross Margin	24.39%
Operating Margin	-223.72%
Pretax Margin	-345.44%
Profit Margin	n/a
EBITDA Margin	-203.44%
EBIT Margin	-223.72%
FCF Margin	n/a

Dividends & Yields

Celularity does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-16.94%
Shareholder Yield	-16.94%
Earnings Yield	-363.57%
FCF Yield	-52.49%

Analyst Forecast

Price Target	n/a
Price Target Difference	n/a
Analyst Consensus	n/a
Analyst Count	n/a
Revenue Growth Forecast (3Y)	157.40%
EPS Growth Forecast (3Y)	n/a

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number	n/a
Graham Upside	n/a

Stock Splits

The last stock split was on February 29, 2024. It was a reverse split with a ratio of 1:10.

Last Split Date	Feb 29, 2024
Split Type	Reverse
Split Ratio	1:10

Scores

Celularity has an Altman Z-Score of -15.06 and a Piotroski F-Score of 2. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score	-15.06
Piotroski F-Score	2